These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
636 related articles for article (PubMed ID: 34075578)
1. Exacerbation of immune thrombocytopenia following COVID-19 vaccination. Kuter DJ Br J Haematol; 2021 Nov; 195(3):365-370. PubMed ID: 34075578 [TBL] [Abstract][Full Text] [Related]
2. COVID-19 vaccination in patients with immune thrombocytopenia. Visser C; Swinkels M; van Werkhoven ED; Croles FN; Noordzij-Nooteboom HS; Eefting M; Last-Koopmans SM; Idink C; Westerweel PE; Santbergen B; Jobse PA; Baboe F; ; Te Boekhorst PAW; Leebeek FWG; Levin MD; Kruip MJHA; Jansen AJG Blood Adv; 2022 Mar; 6(6):1637-1644. PubMed ID: 34941989 [TBL] [Abstract][Full Text] [Related]
3. Effects of COVID-19 vaccination on platelet counts and bleeding in children, adolescents, and young adults with immune thrombocytopenia. Kaicker S; Martinko K; Bussel JB Pediatr Blood Cancer; 2023 Jan; 70(1):e30051. PubMed ID: 36317671 [TBL] [Abstract][Full Text] [Related]
4. Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination. Lee EJ; Cines DB; Gernsheimer T; Kessler C; Michel M; Tarantino MD; Semple JW; Arnold DM; Godeau B; Lambert MP; Bussel JB Am J Hematol; 2021 May; 96(5):534-537. PubMed ID: 33606296 [No Abstract] [Full Text] [Related]
5. Major hemorrhage in children with idiopathic thrombocytopenic purpura: immediate response to therapy and long-term outcome. Medeiros D; Buchanan GR J Pediatr; 1998 Sep; 133(3):334-9. PubMed ID: 9738712 [TBL] [Abstract][Full Text] [Related]
6. Platelet dropping, bleeding and new treatment requirements in ITP patients after inactivated COVID-19 vaccination. Zhan XY; Chen H; Kong H; Meng T; Ye J; Liu Y; Ng MHL; Li L; Zhang Y; Huang J; Peng Q; Chen C; He Y; Yang M Immunol Lett; 2023 Dec; 264():56-63. PubMed ID: 38006954 [TBL] [Abstract][Full Text] [Related]
7. Relapses of Immune Thrombocytopenia after the Second and Booster Doses of BNT162b2 Vaccine. Ratajczak-Enselme M; Mutoni GC; Desmeules J; Favet L; Ing Lorenzini K Acta Haematol; 2023; 146(1):52-57. PubMed ID: 36327915 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP). Hong J; Bang SM; Mun YC; Yhim HY; Lee J; Lim HS; Oh D; J Korean Med Sci; 2018 May; 33(19):e142. PubMed ID: 29736158 [TBL] [Abstract][Full Text] [Related]
9. Severe Hemorrhage in Chinese Children With Immune Thrombocytopenia. Zhou F; Xu Y; Zhang Z; Wu X; Jin R J Pediatr Hematol Oncol; 2015 Apr; 37(3):e158-61. PubMed ID: 25493457 [TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP. Lee EJ; Beltrami-Moreira M; Al-Samkari H; Cuker A; DiRaimo J; Gernsheimer T; Kruse A; Kessler C; Kruse C; Leavitt AD; Lee AI; Liebman HA; Newland AC; Ray AE; Tarantino MD; Thachil J; Kuter DJ; Cines DB; Bussel JB Blood; 2022 Mar; 139(10):1564-1574. PubMed ID: 34587251 [TBL] [Abstract][Full Text] [Related]
11. Risk factors and predictors of treatment responses and complications in immune thrombocytopenia. Ong SY; Tan CW; Ramya V; Malik AA; Lee XH; Hwang JCC; Yang Y; Ng HJ; Lee LH Ann Hematol; 2021 Mar; 100(3):645-651. PubMed ID: 33515047 [TBL] [Abstract][Full Text] [Related]
12. A real-world study of immune thrombocytopenia management during the COVID-19 pandemic in the UK. Rampotas A; Watson E; Burton K; Hill QA; Pavord S Br J Haematol; 2022 Jan; 196(2):351-355. PubMed ID: 34448203 [TBL] [Abstract][Full Text] [Related]
13. Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study. Palau J; Sancho E; Herrera M; Sánchez S; Mingot ME; Upegui RI; Rodríguez Salazar MJ; de la Cruz F; Fernández MC; González López TJ; Hernández JJ; Ríos E; López-Fernández MF; García M; Hernández JÁ; Sanz MA Hematology; 2017 Sep; 22(8):484-492. PubMed ID: 28415913 [TBL] [Abstract][Full Text] [Related]
14. Outcomes and management of immune thrombocytopenia secondary to COVID-19: Cleveland clinic experience. Kewan T; Gunaratne TN; Mushtaq K; Alayan D; Daw H; Haddad A Transfusion; 2021 Jul; 61(7):2014-2018. PubMed ID: 33724474 [TBL] [Abstract][Full Text] [Related]
15. Exacerbation of immune thrombocytopenia following initial and booster vaccination with Pfizer-BioNTech COVID-19 vaccine. Aharoni M; Leader A; Shochat T; Raanani P; Spectre G Platelets; 2022 Jul; 33(5):781-786. PubMed ID: 35536172 [TBL] [Abstract][Full Text] [Related]
16. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura. El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649 [TBL] [Abstract][Full Text] [Related]
17. Immune thrombocytopenia in the elderly: clinical course in 525 patients from a single center in China. Zhou H; Fu R; Wang H; Zhou F; Li H; Zhou Z; Zhang L; Yang R Ann Hematol; 2013 Jan; 92(1):79-87. PubMed ID: 22956151 [TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of chronic idiopathic thrombocytopenia in Chinese children. Wong MS; Chan GC; Ha SY; Lau YL J Pediatr Hematol Oncol; 2002 Nov; 24(8):648-52. PubMed ID: 12439037 [TBL] [Abstract][Full Text] [Related]
19. Autoimmune thrombocytopenia: Current treatment options in adults with a focus on novel drugs. Witkowski M; Witkowska M; Robak T Eur J Haematol; 2019 Dec; 103(6):531-541. PubMed ID: 31449692 [TBL] [Abstract][Full Text] [Related]
20. Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group (ICIS). Neunert CE; Buchanan GR; Imbach P; Bolton-Maggs PH; Bennett CM; Neufeld E; Vesely SK; Adix L; Blanchette VS; Kühne T; Blood; 2013 May; 121(22):4457-62. PubMed ID: 23550040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]